Skip to content
GPT Healthcare logo

GPT Healthcare

GPTHEALTH NSE
₹133.98 +1.53 (+1.16%)
Market Cap
₹1,099 Cr
P/E
21.10
View as Markdown
MCP
Close 20 Nov 2026 ₹133.98 1Y −7.04 −4.99%
Start ₹141.02

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
19.90%
Debt to Equity
0.32
EPS (TTM)
₹6.35
Book Value
₹34.73
Market Cap
₹1,099 Cr
P/E (TTM)
21.10
P/B
3.86
ROE
16.70%
Dividend Yield
0.76%
EBITDA
₹78.80 Cr
52W High
₹175.00
52W Low
₹115.00
Day Range
₹131.41 – ₹137.90
Volume
1,28,571

Peer Comparison

Healthcare › Healthcare Services › Hospital

GPT Healthcare peer comparison
9,200.0059.001,32,28212.470.23%21.50%17.40%27,6302,337
1,081.0076.231,05,2159.280.20%14.70%14.70%9,1461,380
702.20101.7792,3666.010.00%6.72%8.30%12,370873
779.30110.7067,9298.720.41%11.30%11.60%6,508564
825.0059.9662,2845.940.13%11.20%13.40%9,9101,061
1,480.2064.3339,7989.200.03%15.20%17.40%5,053613
1,943.7046.2539,7227.940.24%20.50%15.50%10,273859
GPT Healthcare (this company)
133.9821.101,0993.860.74%16.70%19.90%50852
Median 8 companies953.0062.1565,1078.330.22%14.95%15.10%9,528866

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

60 Good

Data confidence 100/100

Category scores

Quality
67
Strong
Returns, margins, earnings quality 22% weight
Valuation
75
Strong
Cheap vs sector & own history 24% weight
Growth
64
Good
Sales & profit trajectory 9% weight
Financial Health
43
Weak
Solvency, leverage, coverage 9% weight
Momentum
28
Poor
Trend strength, vol-adjusted 12% weight
Ownership
55
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 49.9%

No weaknesses listed

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1234
OscillatorsBullish234
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
38.66
Neutral
MACD (12,26,9)
−2.00
Bearish
SMA (50)
146.12
Bearish
SMA (200)
143.10
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
5Y+14.25%
3Y+9.43%
1Y+16.22%
TTM+18.41%

Net profit

Net profit growth by window
5Y+14.87%
3Y+2.50%
1Y−16.00%
TTM+18.18%

Operating cash flow

Operating cash flow growth by window
5Y+13.50%
3Y+7.06%
1Y+20.90%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−2.19 pp
3Y−2.53 pp
1Y−2.42 pp
TTM−0.41 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2020₹212 Cr
Mar 2021₹243 Cr
Mar 2022₹337 Cr
Mar 2023₹361 Cr
Mar 2024₹400 Cr
Mar 2025₹407 Cr
Mar 2026₹473 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020₹11.00 Cr
Mar 2021₹21.00 Cr
Mar 2022₹42.00 Cr
Mar 2023₹39.00 Cr
Mar 2024₹48.00 Cr
Mar 2025₹50.00 Cr
Mar 2026₹42.00 Cr

Analyst Forecasts

Forecast For
Mar 27 consensus · Price
₹136.00 −9.8% vs Sep 26
Reported High Mean Low

Quarterly Results

₹ Cr
GPTHEALTH quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
108
97
99
98
106
102
101
107
119
120
126
126
136
Expenses
83
76
76
80
82
81
81
90
96
99
103
102
109
Operating Profit
25
21
23
18
23
21
21
17
23
21
23
24
27
OPM %
23%
22%
23%
18%
22%
21%
20%
16%
19%
17%
18%
19%
20%
Other Income
1
1
2
2
3
2
2
2
1
1
2
2
2.94
Interest
2
2
2
1
1
1
1
2
2
2
2
2
2.1
Depreciation
4
4
5
5
5
5
5
6
7
7
7
7
7.05
PBT
19
16
18
15
21
18
16
11
15
13
16
17
20.68
Tax %
31%
28%
30%
32%
28%
30%
21%
31%
30%
27%
8%
26%
25%
Net Profit
14
11
13
10
15
12
13
8
11
9
15
13
15.4
EPS (₹)
1.69
1.44
1.56
1.21
1.81
1.49
1.57
0.94
1.29
1.14
1.78
1.55
1.88
YoY Sales growth
—
4
3
2
−2
6
2
10
13
18
25
18
14

Profit & Loss

₹ Cr
GPTHEALTH profit and loss, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
212
243
337
361
400
407
473
508
Expenses
176
194
263
287
312
324
387
413
Operating Profit
36
49
74
74
88
83
85
95
OPM %
17%
20%
22%
21%
22%
20%
18%
19%
Other Income
4
6
5
6
5
8
5.95
8
Interest
14
14
11
9
7
3
8
9
Depreciation
11
12
14
15
18
19
27
28
PBT
15
29
54
56
68
69
55
66
Tax %
26%
27%
23%
30%
30%
28%
23%
—
Net Profit
11
21
42
39
48
50
42
52
EPS (₹)
1.37
2.64
5.21
4.88
5.82
6.08
5.15
6.35
Div. Payout %
0%
47%
0%
102%
60%
41%
49%
—
Sales growth
—
15
39
7
11
2
16
18

Balance Sheet

₹ Cr
GPTHEALTH balance sheet, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
18
18
80
80
82
82
82
82
Reserves
109
116
78
85
136
166
187
203
Borrowings
157
166
102
82
31
35
91
92
Other Liabilities
25
18
63
79
96
101
104
103
Total Liabilities
308
317
323
327
346
384
465
480
Fixed Assets
226
220
220
228
224
228
342
343
CWIP
2
0
1
3
6
46
1
8
Investments
1
1
10
13
30
32
43
45
Other Assets
80
97
92
83
85
78
79
83
Total Assets
308
317
323
327
346
384
465
480

Cash Flow

₹ Cr
GPTHEALTH cash flow, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
41
43
66
66
69
67
81
Investing
−54
−16
−5
5
−25
−33
−47
Financing
12
−22
−57
−73
−48
−35
−31
Net Cash Flow
−1
4
3
−2
−5
0
2
Free Cash Flow
−5
38
59
58
50
18
40
CFO/EBITDA
116
88
107
103
95
101
110

Ratios

GPTHEALTH financial ratios, annual
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
30
26
15
21
22
18
16
Inventory Days
60
41
30
43
36
41
43
Days Payable
314
165
121
161
165
161
170
Cash Conversion Cycle
−224
−98
−76
−97
−106
−102
−112
Working Capital Days
−4
32
3
−18
−16
−28
−29
ROCE %
—
14%
23%
25%
30%
27%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view GPT Healthcare insights

63 extracted metrics across FY20–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 65.57%
  • Public 18.10%
  • DIIs 7.10%
  • Others 6.22%
  • FIIs 3.00%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

Frequently Asked Questions about GPT Healthcare

What does GPT Healthcare Ltd do?
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services
Where is GPT Healthcare Ltd (GPTHEALTH) listed?
GPT Healthcare Ltd trades as GPTHEALTH on the NSE and under code 544131 on the BSE.
Which sector does GPT Healthcare Ltd belong to?
GPT Healthcare Ltd is classified under the Healthcare sector, in the Healthcare Services industry.
What is the market capitalisation of GPT Healthcare Ltd?
GPT Healthcare Ltd has a market capitalisation of ₹1,099 Cr as of 20 Nov 2026, which places it in the Microcap band.
What is the PE ratio of GPT Healthcare Ltd?
GPT Healthcare Ltd trades at a PE ratio of 21.10 as of 20 Nov 2026, on earnings per share of ₹6.35, against a book value of ₹34.73 per share.
What is the 52-week high and low of GPT Healthcare Ltd?
Over the last 52 weeks GPT Healthcare Ltd has traded between ₹115 and ₹175 as of 20 Nov 2026.
Does GPT Healthcare Ltd pay dividends?
GPT Healthcare Ltd has a dividend yield of 0.76%.
What is the Return on Equity (ROE) of GPT Healthcare Ltd?
GPT Healthcare Ltd reported a return on equity of 16.70%. Its debt-to-equity ratio is 0.32.

Company Information

Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services

CEO Dr. Om Prakash Tantia
Employees 1,924
Listed 29 Feb 2024
Face Value ₹10
Shares Outstanding 8,20,54,823

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GPTHEALTH.md for GPT Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More